Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study

SIMPLE SUMMARY: In patients diagnosed with acute myeloid leukemia (AML), relapse remains the main cause of mortality after allogeneic hematopoietic stem cell transplantation (HSCT). The detection of measurable residual disease (MRD) by multiparameter flow cytometry in AML patients undergoing HSCT is...

Descripción completa

Detalles Bibliográficos
Autores principales: Caballero-Velázquez, Teresa, Pérez-López, Olga, Yeguas Bermejo, Ana, Rodríguez Arbolí, Eduardo, Colado Varela, Enrique, Sempere Talens, Amparo, Vidriales, María Belén, Solé-Rodríguez, María, Quirós Caso, Covadonga, Pérez López, Estefanía, Reinoso Segura, Marta, Prats-Martín, Concepción, Montesinos, Pau, Pérez-Simón, Jose A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000405/
https://www.ncbi.nlm.nih.gov/pubmed/36900400
http://dx.doi.org/10.3390/cancers15051609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000405/
https://www.ncbi.nlm.nih.gov/pubmed/36900400
http://dx.doi.org/10.3390/cancers15051609

Ejemplares similares